Comparative effectiveness of metronidazole and vancomycin for treatment of

• Tác giả: Suzanne E Dahlberg, Kaitlyn Daugherty, Ciarán P Kelly, Larry K Kociolek, Nira R Pollock, Morgan E Ryan, Thomas J Sandora, Timothy J Savage
• Ngôn ngữ: eng
• Ký hiệu phân loại: 629.13334 Aerospace engineering
• Thông tin xuất bản: England : Antimicrobial stewardship & healthcare epidemiology : ASHE , 2025
• Bộ sưu tập: NCBI
• ID: 724845

Tóm tắt

 OBJECTIVE: To compare rates of clinical response in children with DESIGN: Retrospective cohort study was performed as a secondary analysis of a previously established prospective cohort of hospitalized children with CDI. For 187 participants 2-17 years of age who were treated with metronidazole and/or vancomycin, the primary outcome of clinical response (defined as resolution of diarrhea within 5 days of treatment initiation) was identified retrospectively. Baseline variables associated with the primary outcome were included in a logistic regression propensity score model estimating the likelihood of receiving metronidazole vs vancomycin. Logistic regression using inverse probability of treatment weighting (IPTW) was used to estimate the effect of treatment on clinical response. RESULTS: One hundred seven subjects received metronidazole and 80 subjects received vancomycin as primary treatment. There was no univariable association between treatment group and clinical response
  78.30% (N = 83) of the metronidazole treatment group and 78.75% (N = 63) of the vancomycin group achieved clinical response ( CONCLUSIONS: In this observational cohort study of pediatric inpatients with CDI, the rate of resolution of diarrhea after 5 days of treatment did not differ among children who received metronidazole vs vancomycin.